In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression.
Stocks: 10x Genomics (NASDAQ: TXG)
Check out more of our content here:
Podcasts)
Youtube)
Twitter)
Reach us by Email @ [email protected])
